Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Yacht Buyer
  • Stocks
  • Education
  • Nyse
  • Finance
  • Banking
ncarol.com

Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
ncarol.com/10267063

Trending...
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
Longevity By Nature Logo
TEMECULA, Calif. - ncarol.com -- 16Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results

TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.

Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.

Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."

More on ncarol.com
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League

Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.

"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."

For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.

Contact
Longevity by Nature
abdul@longevitybynature.biz
8774129888


Source: Longevity by Nature

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
  • Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
  • Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry
  • Best Book Publishing Company for Aspiring Authors
  • Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • AKG To Demonstrate New Digital E-catalog Experience Daily At CONEXPO CON/AGG 2026
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
  • STEM For Kids Launches Root Protocol™: A Human Bridge for Gen Alpha's Digital Curiosity Crisis
  • Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
  • 2026 Pre-Season Testing Confirms a Two-Tier Grid as Energy Management Defines Formula 1's New Era
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 113
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • Still Using Ice? FrostSkin Reinvents Hydration
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch

Similar on ncarol.com

  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
  • Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute